National Institutes of Health State-of-the-Science Conference: role of active surveillance in the management of men with localized prostate cancer - sprookjes - yvandenbroek - TriplyDB

National Institutes of Health State-of-the-Science Conference: role of active surveillance in the management of men with localized prostate cancer

National Institutes of Health State-of-the-Science Conference: role of active surveillance in the management of men with localized prostate cancer

http://www.wikidata.org/entity/Q34255849

about

Screening for prostate cancer with prostate-specific antigen testing: American Society of Clinical Oncology Provisional Clinical Opinion.Identifying barriers to patient acceptance of active surveillance: content analysis of online patient communications Using Electronic Health Record Data to Identify Prostate Cancer Patients That May Qualify for Active Surveillance.Association between angiotensin converting enzyme inhibitor or angiotensin receptor blocker use prior to major elective surgery and the risk of acute dialysis Higher anti-depressant dose and major adverse outcomes in moderate chronic kidney disease: a retrospective population-based study.Analysis of the correlation between endorectal MRI response to neoadjuvant chemotherapy and biochemical recurrence in patients with high-risk localized prostate cancer.Treatment decisions for localized prostate cancer: a concept mapping approach Higher dose versus lower dose of antiviral therapy in the treatment of herpes zoster infection in the elderly: a matched retrospective population-based cohort study.Prostate-specific antigen screening in prostate cancer: perspectives on the evidence Expected population impacts of discontinued prostate-specific antigen screening.Detecting chronic kidney disease in population-based administrative databases using an algorithm of hospital encounter and physician claim codes Five-year nationwide follow-up study of active surveillance for prostate cancer Duration of androgen suppression before radiotherapy for localized prostate cancer: radiation therapy oncology group randomized clinical trial 9910.Characteristics and experiences of patients with localized prostate cancer who left an active surveillance program.Nanocytological field carcinogenesis detection to mitigate overdiagnosis of prostate cancer: a proof of concept study Physician variation in management of low-risk prostate cancer: a population-based cohort study Gonadotropin-releasing hormone agonist overuse: urologists' response to reimbursement and characteristics associated with persistent overuse Self-Reported Health Status Predicts Other-Cause Mortality in Men with Localized Prostate Cancer: Results from the Prostate Cancer Outcomes Study.Statin Safety in Chinese: A Population-Based Study of Older Adults Fifteen-year Outcomes Following Conservative Management Among Men Aged 65 Years or Older with Localized Prostate Cancer Risk of Ventricular Arrhythmia with Citalopram and Escitalopram: A Population-Based Study.Active surveillance for low-risk prostate cancer.Pathological characteristics of low risk prostate cancer based on totally embedded prostatectomy specimens.Radical prostatectomy versus observation for localized prostate cancer.Testosterone therapy in men with prostate cancer: literature review, clinical experience, and recommendations.Gleason score 6 adenocarcinoma: should it be labeled as cancer?Commentary on the State-of-the-Science Conference on the role of active surveillance in the management of men with localized prostate cancer.Role of active surveillance in the management of localized prostate cancer.Focal brain inflammation and autism.Intermediate and Longer-Term Outcomes From a Prospective Active-Surveillance Program for Favorable-Risk Prostate Cancer.Harnessing novel modalities: field carcinogenesis detection for personalizing prostate cancer management Patients' Survival Expectations With and Without Their Chosen Treatment for Prostate Cancer.Urinary TMPRSS2:ERG and PCA3 in an active surveillance cohort: results from a baseline analysis in the Canary Prostate Active Surveillance Study.Should Gleason 6 be labeled as cancer?The Prostate Cancer Intervention Versus Observation Trial (PIVOT) in Perspective.Low prostate-specific antigen and no Gleason score upgrade despite more extensive cancer during active surveillance predicts insignificant prostate cancer at radical prostatectomy.Targeted proteomics identifies liquid-biopsy signatures for extracapsular prostate cancer.Economic Analysis of Prostate-Specific Antigen Screening and Selective Treatment Strategies African American men with low-grade prostate cancer have increased disease recurrence after prostatectomy compared with Caucasian men.The Study of Active Monitoring in Sweden (SAMS): a randomized study comparing two different follow-up schedules for active surveillance of low-risk prostate cancer

P2860

Q24620320-BBD66871-DE68-4496-96AC-534D734121CF Q30417174-E7CA456E-7226-4B92-8C86-0F5445E801D3 Q31133702-7FC3AF20-82D4-4EBB-96E2-FD9B5F9F92EE Q33613082-BC0624CC-6BF5-42B4-891E-047D1BA189B7 Q33623785-07930FBD-DDB4-427F-B858-0319C086014C Q33631383-E2E224CB-E791-4487-9E24-89EBC8FEE14C Q34028603-1E24EE3F-4D80-46EE-87E2-A6A6E9743CE1 Q34152542-23F9F5C6-EA88-44BA-99E1-C208A8063E74 Q34354430-291BED85-3468-4941-938A-0F6E5426278F Q34458237-A173833E-E07A-4549-B7B1-368062D83EA7 Q34656619-7406A71D-3AAC-4AC1-9BE2-57D26357DB3C Q34791420-B589D9D9-5883-40A1-8F8B-EC3308049B44 Q34996654-7D3C30FF-6053-4632-A36B-FCD6DE36B624 Q35095972-FB1A44EB-DA84-4CCB-B69C-283B4E6A2888 Q35112929-1647487B-6C2F-43B8-B329-353DC0ABF754 Q35213290-4AFFD73C-7865-4F29-92C6-94575D28317E Q35602510-18EE351C-A27A-43AF-B5B2-CBA7E44AC351 Q35752688-3E7E0CE8-7DFF-4846-9176-B9C2D77535E3 Q35949456-1B1F5FFA-B522-4103-8167-6D4CCCDD84DF Q36075018-9D613035-FADD-434B-8780-E9FCF3286D54 Q36101440-04DBE09C-812C-446D-911E-995F26F4BF88 Q36141777-875E11C5-DD9F-4F07-8468-982E35AB907C Q36181965-8A019732-5812-4FC3-992A-F682C314C6D1 Q36194308-D54ED061-2F74-43E0-B838-E5F367928AB6 Q36293127-E991BCB9-B7A2-47A0-BB2E-3C38AD6F5FAB Q36449197-3C3801F8-232B-4AFD-A0E1-954EA05158CD Q36520434-72807E3F-6C2C-42A5-9890-4131412E04BF Q36520452-6298BA36-583F-42E2-9DA4-0DA4A5E3E623 Q36766675-4A7DABED-42FF-4F49-B405-3BD145AFD5DC Q36892392-D59751BE-41BB-4CC0-B7C6-27AB7465EC18 Q36904803-46B70232-3B21-4053-B4E4-555E3E60F7AF Q36905270-0866886B-C1E0-4C8A-B15E-A8214BDEC9DE Q36907574-AD52F104-E474-4D13-AF87-8D36364760D3 Q36931932-0356B8B2-79EE-49D5-A68F-DFC02A77A7A2 Q37017602-F128F329-FF7F-4697-A514-B222AA25AB96 Q37023829-97237B1D-0941-49E9-9350-664316B56834 Q37060938-5C430476-5DB6-4041-954B-E2D89AC83C5D Q37095655-CC7E4E1D-3FD3-453E-968E-5333493CC92A Q37167067-9ED5C0E6-DB96-4508-BB6D-ECB3ED4EDC99 Q37260055-320FD8A8-5175-4173-911E-528BD2776442

P2860

National Institutes of Health State-of-the-Science Conference: role of active surveillance in the management of men with localized prostate cancer

http://www.wikidata.org/entity/Q34255849

description

2012 nî lūn-bûn

@nan

2012 թուականի Փետրուարին հրատարակուած գիտական յօդուած

@hyw

2012 թվականի փետրվարին հրատարակված գիտական հոդված

@hy

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

name

National Institutes of Health ...... with localized prostate cancer

@ast

National Institutes of Health ...... with localized prostate cancer

@en

National Institutes of Health ...... with localized prostate cancer

@nl

type

label

National Institutes of Health ...... with localized prostate cancer

@ast

National Institutes of Health ...... with localized prostate cancer

@en

National Institutes of Health ...... with localized prostate cancer

@nl

prefLabel

National Institutes of Health ...... with localized prostate cancer

@ast

National Institutes of Health ...... with localized prostate cancer

@en

National Institutes of Health ...... with localized prostate cancer

@nl

P1433

Q34255849-9E1F66D7-B025-429E-9B45-9693F3403A28

P1476

Q34255849-94817880-BC30-4FDB-87D8-08CCB9CD290C

P2093

Q34255849-1F8FF993-8BD3-43A8-BBE3-9C943C9F66DA

Q34255849-31C8FACB-D0FE-489E-B010-A2F911469A7C

Q34255849-358F4FC4-C39B-4056-ACF9-088A8E66998A

Q34255849-45212DB7-1145-4A68-9BED-824BAC4F72F7

Q34255849-509657DA-E9A8-4939-9621-1BC3A183A3CB

Q34255849-75B97B90-1BF2-4961-95CC-37A8DE6A5E0A

Q34255849-81F6A305-A3B8-4BC8-8F9B-57556A59E79F

Q34255849-82060330-E27C-4425-8DDB-E966A246ABC6

Q34255849-85A334A2-7952-432F-A5DB-C79B71B8A589

Q34255849-8B438877-993C-47ED-B915-EDC9F1121C2C

P304

Q34255849-13CEE81C-D034-4B69-91D4-749B52911551

P31

Q34255849-9C8B145E-BE59-4FA7-AAE4-7EB6BD0B893F

P356

Q34255849-8E823A5B-81AF-4FFB-9BCF-29F18018AB10

P407

Q34255849-4F7EFE4A-38DD-4532-B347-CC1AB61973C3

P433

Q34255849-5387E17B-362E-4F2E-8F08-A765B0D165B1

P478

Q34255849-73939651-7342-4D4F-890C-69965A584137

P50

Q34255849-42DF864B-DA0B-4261-8B13-7CD7820509FE

P577

Q34255849-8E1CB516-36E8-4131-BB22-826FB81CC53E

P698

Q34255849-54165193-41E6-4087-A28A-2ECB1798386A

P932

Q34255849-C26AD86E-4139-46F2-B74B-FF20A440BBAD

P356

0003-4819-156-8-201204170-00401

P1433

Annals of Internal Medicine

P1476

National Institutes of Health ...... with localized prostate cancer

@en

P2093

Barry A Kogan

http://www.w3.org/2001/XMLSchema#string

Charles F Lynch

http://www.w3.org/2001/XMLSchema#string

Eric J Seifter

http://www.w3.org/2001/XMLSchema#string

Everett Dodson

http://www.w3.org/2001/XMLSchema#string

Hunter Wessells

http://www.w3.org/2001/XMLSchema#string

Janet A Tooze

http://www.w3.org/2001/XMLSchema#string

John M Barry

http://www.w3.org/2001/XMLSchema#string

Kasisomayajula Viswanath

http://www.w3.org/2001/XMLSchema#string

Lee Newcomer

http://www.w3.org/2001/XMLSchema#string

M Elizabeth Hammond

http://www.w3.org/2001/XMLSchema#string

P304

591-595

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.7326/0003-4819-156-8-201204170-00401

http://www.w3.org/2001/XMLSchema#string

P407

P433

8

http://www.w3.org/2001/XMLSchema#string

P478

156

http://www.w3.org/2001/XMLSchema#string

P50

P577

2012-02-20T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

22351514

http://www.w3.org/2001/XMLSchema#string

P932

4774889

http://www.w3.org/2001/XMLSchema#string